(s)-(-)-nadifloxacin Uses, Dosage, Side Effects and more
(s)-(-)-nadifloxacin is under investigation in clinical trial NCT03405064 (Comparative Study of (s)-(-)-nadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)).
| Trade Name | (s)-(-)-nadifloxacin |
| Generic | Levonadifloxacin |
| Levonadifloxacin Other Names | (s)-(-)-nadifloxacin, Levonadifloxacin, Nadifloxacin, (s)-, Wck 771 free base, Wck-771 free base, Wck771 free base |
| Type | |
| Formula | C19H21FN2O4 |
| Weight | Average: 360.385 Monoisotopic: 360.148535327 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
